* Orthofix Medical Inc OFIX.OQ OFIX.O is expected
to show a
rise in quarterly revenue when it reports results on November
3.
* The Lewisville Texas-based company is expected to report
a
0.5% increase in revenue to $113 million from $112.43 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Orthofix Medical
Inc is
for earnings of 12 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Orthofix
Medical
Inc is $30, above its last closing price of $16.06.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.10 0.10 0.08 Missed -20
Mar. 31 2022 0.10 0.09 -0.10 Missed -215.4
Dec. 31 2021 0.13 0.13 0.27 Beat 107.7
Sep. 30 2021 0.11 0.11 0.10 Missed -10.4
Jun. 0.13 0.11 0.32 Beat 190.9
30 2021
Mar. 31 2021 0.01 0.02 0.17 Beat 709.5
Dec. 31 2020 0.17 0.19 0.44 Beat 126.8
Sep. 30 2020 -0.29 -0.36 0.31 Beat 185.2
This summary was machine generated November 1 at 18:34 GMT. All
figures in US dollars unless otherwise stated